Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) has issued an announcement.
Epsilon Healthcare Limited has had its securities reinstated to quotation on the ASX following a suspension and its emergence from voluntary administration in June 2024, after satisfying the exchange’s conditions. The company has undertaken an extensive internal overhaul of its operations, financial position, governance and disclosure practices, which the board and management say has stabilised the business, rebuilt stakeholder confidence and positioned Epsilon to pursue a disciplined and sustainable growth strategy. Over the next 12 months, Epsilon plans to scale its core capabilities in manufacturing, pharmacy and clinical services, develop new products and services, leverage its GMP infrastructure for scalable growth, expand its clinical and pharmacy offerings, and seek strategic opportunities to diversify revenue and strengthen operational resilience. The board also continues a professionally guided legal, forensic and financial review of historical matters involving former directors to ensure shareholder and company interests are protected and, where appropriate, remediated, underscoring a renewed emphasis on governance, transparency and long-term shareholder value.
The most recent analyst rating on (AU:EPN) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited is an Australian healthcare company listed on the ASX that operates across manufacturing, pharmacy and clinical services, leveraging GMP-certified infrastructure and regulatory credentials to deliver products and services to patients, clients and consumers. The company is building a patient-centric ecosystem supported by its Epsilon Pharmacy subsidiary and clinic operations, with a focus on innovative healthcare offerings and scalable growth within the broader healthcare value chain.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
Learn more about EPN stock on TipRanks’ Stock Analysis page.